Endoscopic therapy for gastroesophageal reflux disease: where are we, where are we going?

Curr Opin Gastroenterol. 2023 Sep 1;39(5):381-389. doi: 10.1097/MOG.0000000000000968. Epub 2023 Jul 20.

Abstract

Purpose of review: Gastroesophageal reflux disease (GERD) is the most common chronic condition with increasing prevalence in the Western world. Despite medical therapy, a considerable proportion of patients continue to experience symptoms, thus fueling the demand for minimally invasive GERD treatment options. This review will assess the currently available endoscopic approaches by analyzing their outcomes data, indication for use and limitations.

Recent findings: With increasing evidence of the safety and efficacy of endoscopic therapies, recent guidelines and consensus society documents have updated their recommendations for the endoscopic treatment of GERD. In this review, we have comprehensively assessed the current landscape of endoscopic approaches for the treatment of GERD and provided insight into future directions.

Summary: Endoscopic therapies for GERD show promise as new treatments emerge and existing therapies evolve into safer and more reproducible options. They are well positioned to cater to a large subset of the population suffering from chronic condition of GERD.

Publication types

  • Review

MeSH terms

  • Endoscopy*
  • Gastroesophageal Reflux* / diagnosis
  • Humans